In vitro Antifungal Susceptibility Testing of Clinical and Environmental Fusarium Isolates in Iran
暂无分享,去创建一个
H. Aghaei | F. Zaini | P. Kordbacheh | M. Safara | R. Kachuei | Setareh Agha Kuchak Afshari | Shahram Mahmoudi | S. A. K. Afshari
[1] J. Meis,et al. Fusarium species causing eumycetoma: Report of two cases and comprehensive review of the literature , 2017, Mycoses.
[2] G. S. de Hoog,et al. Phylogenetic analysis of dermatophyte species using DNA sequence polymorphism in calmodulin gene. , 2016, Medical mycology.
[3] J. Meis,et al. In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis. , 2016, The Journal of antimicrobial chemotherapy.
[4] J. Meis,et al. Fusarium: Molecular Diversity and Intrinsic Drug Resistance , 2016, PLoS pathogens.
[5] M. Shams-Ghahfarokhi,et al. Giberella fujikuroi species complex isolated from maize and wheat in Iran: distribution, molecular identification and fumonisin B1 in vitro biosynthesis. , 2016, Journal of the science of food and agriculture.
[6] J. Meis,et al. Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Genus Fusarium Causing Human Keratomycosis in South India. , 2016, Medical mycology.
[7] F. Zaini,et al. The antagonistic effects of Candida parapsilosis on the growth of Fusarium species and fumonisin production , 2016, Current medical mycology.
[8] J. Meis,et al. Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015 , 2016, Emerging microbes & infections.
[9] T. Boekhout,et al. Phylogenetic diversity of human pathogenic Fusarium and emergence of uncommon virulent species. , 2015, The Journal of infection.
[10] B. Sampaio-Maia,et al. Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[11] J. Meis,et al. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. , 2014, The Journal of antimicrobial chemotherapy.
[12] A. Quesada,et al. Polymorphism of genes encoding PmrAB in colistin-resistant strains of Escherichia coli and Salmonella enterica isolated from poultry and swine. , 2015, The Journal of antimicrobial chemotherapy.
[13] L. Pagano,et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[14] Koichiro Tamura,et al. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.
[15] Springer-Verlag,et al. Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[16] S. Balajee,et al. Molecular analyses of Fusarium isolates recovered from a cluster of invasive mold infections in a Brazilian hospital , 2013, BMC Infectious Diseases.
[17] M. Suh,et al. Onychomycosis Due to Nondermatophytic Molds , 2012, Annals of dermatology.
[18] B. Piraccini,et al. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. , 2012, Journal of the American Academy of Dermatology.
[19] F. Grenouillet,et al. International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole , 2010, Antimicrobial Agents and Chemotherapy.
[20] M. Chadeganipour,et al. Study of onychomycosis in Isfahan, Iran , 2010, Mycoses.
[21] S. A. Ghiasian,et al. Onychomycosis in Iran: epidemiology, causative agents and clinical features. , 2010, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.
[22] S. Restrepo,et al. Fusarium species detected in onychomycosis in Colombia , 2009, Mycoses.
[23] J. Guarro,et al. Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here? , 2008, Journal of Clinical Microbiology.
[24] Kerry O'Donnell,et al. Molecular Phylogenetic Diversity, Multilocus Haplotype Nomenclature, and In Vitro Antifungal Resistance within the Fusarium solani Species Complex , 2008, Journal of Clinical Microbiology.
[25] J. Guarro,et al. In Vitro Antifungal Susceptibility and Molecular Characterization of Clinical Isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum , 2008, Antimicrobial Agents and Chemotherapy.
[26] E. Mellado,et al. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. , 2008, The Journal of antimicrobial chemotherapy.
[27] E. Anaissie,et al. Fusarium Infections in Immunocompromised Patients , 2007, Clinical Microbiology Reviews.
[28] J. Guarro,et al. Universal In Vitro Antifungal Resistance of Genetic Clades of the Fusarium solani Species Complex , 2007, Antimicrobial Agents and Chemotherapy.
[29] H. Kistler,et al. Heading for disaster: Fusarium graminearum on cereal crops. , 2004, Molecular plant pathology.
[30] S. Rezayat,et al. Mycoflora of Iranian Maize Harvested in the Main Production Areas in 2000 , 2004, Mycopathologia.
[31] E. Anaissie,et al. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] J. Rex,et al. In Vitro Activities of Investigational Triazoles against Fusarium Species: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test Results , 2002, Antimicrobial Agents and Chemotherapy.
[33] B. Nare,et al. Evaluation of a Cyclic GMP-Dependent Protein Kinase Inhibitor in Treatment of Murine Toxoplasmosis: Gamma Interferon Is Required for Efficacy , 2002, Antimicrobial Agents and Chemotherapy.
[34] B. Piraccini,et al. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. , 2000, Journal of the American Academy of Dermatology.
[35] E. Anaissie,et al. Taxonomy, biology, and clinical aspects of Fusarium species , 1994, Clinical Microbiology Reviews.
[36] G. Wickern. Fusarium allergic fungal sinusitis. , 1993, The Journal of allergy and clinical immunology.